Ascentage Pharma Group International AAPG
NASDAQ AAPG
$16.34 +0.43 (+2.79%)
As of: Oct 21, 2026 · 2:02 PM EDT

Ascentage Pharma Group International (AAPG) Current Deferred Tax Assets (2023 - 2026)

Updated

Analysis

Ascentage Pharma Group International (AAPG) Current Deferred Tax Assets (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Ascentage Pharma Group International 1.45 Bn 417.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.39 Mn
Dec 31, 2025 185.93 Mn
Jun 30, 2025 93.45 Mn
Dec 31, 2024 42.14 Mn
Dec 31, 2023 57.69 Mn
API Access

Ascentage Pharma Group International Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY